Bjorn R. Olsen, M.D. Ph.D.
Professor, Department of Developmental biology, Harvard School of Dental Medicine
Harvard-Forsyth Professor of Oral Biology, Department of Harvard-forsyth oral biology, Harvard School of Dental Medicine
Hersey Professor of Cell Biology, Department of Cell Biology, Harvard Medical School
Dean for Research, Developmental biology, Harvard School of Dental Medicine
Dean of Research, Harvard Dental School, Harvard School of Dental Medicine
Contact Info
Bjorn Olsen
Harvard Medical School
190 Longwood Avenue
Boston, MA, 02115
Phone: 617-432-1874
Fax: 617-432-0638
bjorn_olsen@hms.harvard.edu
Administrative Assistant
Harvard Dental School
Harvard School of Dental Medicine
190 Longwood Avenue
Boston, MA, 02115
Phone: 617-432-2359
Fax: 617-432-0638
yulia_pittel@hms.harvard.edu
Harvard Medical School
190 Longwood Avenue
Boston, MA, 02115
Phone: 617-432-1874
Fax: 617-432-0638
bjorn_olsen@hms.harvard.edu
Assistant
Yulia PittelAdministrative Assistant
Harvard Dental School
Harvard School of Dental Medicine
190 Longwood Avenue
Boston, MA, 02115
Phone: 617-432-2359
Fax: 617-432-0638
yulia_pittel@hms.harvard.edu
DF/HCC Program Affiliation
Angiogenesis, Invasion, and MetastasisResearch Abstract
This laboratory studies tissue and organ morphogenesis. Work is currently directed at three project areas.In the first project we study skeletal morphogenesis and growth. We are interested in genes that control differentiation of mesenchymal cells to chondrocytes and osteoblasts, the control of spatial patterns of mesenchymal condensations during skeletal development and tooth formation, the molecular mechanisms controlling the formation of ossification centers, and the regulation of proliferation and differentiation of chondrocytes in growth plates. In addition to using transgenic mice in studies of specific genes, we make extensive use of genetic approaches in mice and humans. This includes mapping of inherited disorders, gene identification and mutation detection.
In the second project we investigate the molecular basis for vascular morphogenesis, using a combination of human genetics and studies of cells in culture. In addition, we use gene targeting to generate mice with inactivated alleles for collagens that are expressed in vascular walls.
In the third project we are studying genetic risk factors for osteoarthritis in humans. One approach involves identification of mutations responsible for early-onset osteoarthritis as part of inherited osteochondrodysplasias; in other studies we are screening a population of patients with osteoarthritis for mutations in candidate genes.




